Dr. med. Ralf Langhoff

Vorstandstätigkeiten, Mitgliedschaften, Ämter

• DGA (Deutsche Gesellschaft für Angiologie, Gesellschaft für Gefäßmedizin e.V.), Vorstand
• Kommission Interventionelle Angiologie der DGA, Vorsitzender
• Kardionet – Wissenschaftlicher Beirat
• RECCORD (Recording Courses of Vascular Diseases) Versorgungsforschung- Wissenschaftlicher Beirat
• Curriculum Intervention (Cur-ITaG) der DGA und DGK – Leiter der Steuerungsgruppe
• Mitglied des Lenkungsausschuss der S3-Leilinie Carotis
• DGIM (Deutsche Gesellschaft für Innere Medizin)
• DGA (Deutsche Gesellschaft für Angiologie)
• ISEVS (International Society of Endovascular Specialists)
• Facharztprüfer Ärztekammer Berlin
• Gutachter

Wissenschaftliche Tätigkeiten/ständige, aktive Kongressverpflichtungen

National:

• Angiologie-Tage Berlin – Wissenschaftliche Leitung, Course Director
• GMS (Gefäßmedizinisches Symposium Berlin) – Wissenschaftliche Leitung, Course Director
• DGA-Jahrestagung (Deutsche Gesellschaft für Angiologie) – Kongresspräsident 2021
• Interventionskongress der DGA (Deutsche Gesellschaft für Angiologie) – Kongresspräsident 2021
• DGG-Jahrestagung (Deutsche Gesellschaft für Gefäßchirugie)
• DGK-Jahres -und Herbsttagung (Deutsche Gesellschaft für Kardiologie)
• Nationaler CLI-Kongress
• Heidelberger Angiologietag, Universität Heidelberg

International:

• JET (Japan Endovascular Treatment, Osaka/Kobe/Tokyo)- Faculty, Scientific Board
• LINC (Leipzig Interventional Course) – Faculty, Scientific Board
• PVI (Paris Vascular insights) – Faculty, Scientific Board
• AMP (The Amputation Prevention Symposium/Lugano) -Faculty
• BEC (Balkan Endovascular Course, Sofia) – Faculty
• LINC-AP (LINC-Asia Pacific, Hong-Kong) -Faculty
• CIRSE (Cardiovascular and Interventional Radiology Society of Europe) – Faculty
• CCT (Complex Cadiovascular Therapeutics/Kobe Japan) – Faculty
• VERVE (Visisonary Endovascular& Vascular Education/Sydney) – Faculty
• EuroPCR (Paris Course of Revascularisation) – Faculty
• TCT (Trancatheter Cardiovascular Therapeutics, USA)

Gutachten und Review für wissenschaftliche Fachzeitschriften

VASA – European Journal of Vascular Medicine
CCI – Catheterization and Cardiovascular Interventions
JACC -Journal of the American College of Cardiology
JACC Cardiovasc Interv – Journal of the American College of Cardiology Cardiovascular Interventions
EurHeartJ -European Heart Journal
EuroIntervention -Official Journal of EuroPCR

Klinische Studien

Durchführung(Co-PI), Leitung (PI) und Abschluss zahlreicher klinischer Studien aus dem Bereich peripherer Interventionen, Carotis -Interventionen, Bluthochdruck und Thrombosetherapie/-prophylaxe (>40 seit 1999)

Dr.med. Ralf Langhoff
Studium
1986 –1993			Studium der Humanmedizin an der Freien Universität Berlin Experimentelle Promotion über ∝-Rezeptorblockade bei primären Raynaud-Syndrom (Prof. Dr. K.-L. Schulte/Charité -Berlin)
Beruflicher Werdegang
1993 – 1997			Assistenzarzt Abteilung für Kardiologie (Sankt Gertrauden-Krankenhaus, Lehrkrankenhaus der Charité Berlin)
1997 – 1999			Assistenz/-Stationsarzt Intensivstation der Abteilung Innere Medizin, Gefäßzentrum Berlin, Ev. Krankenhaus Königin Elisabeth (KEH), Lehrkrankenhaus der Charité Berlin
1999			Facharzt für Innere Medizin der Landesärztekammer Berlin
2001			Facharzt für Innere Medizin, Schwerpunkt Angiologie der Landesärztekammer Berlin
2001			Oberarzt Abteilung Innere Medizin/ Angiologie am Gefäßzentrum Berlin, Ev. Krankenhaus Königin Elisabeth (KEH), Lehrkrankenhaus der Charité Berlin (Prof. Dr. K.-L. Schulte)
2003			Leitender Oberarzt und Leiter des Katheterlabor am KEH-Berlin
Seit 2011			Vorstandsmitglied ESVM (Europäische Stiftung für Vaskuläre Medizin an der MHB/ Medizinische Hochschule Brandenburg)
Seit 2013			Chefarzt Abteilung Angiologie/Gefäßmedizin am Sankt Gertrauden-Krankenhaus Berlin
Seit 2016			Vorstandsmitglied der Deutschen Gesellschaft für Angiologie (DGA)
Seit 2020			Lehrverpflichtung an der Medizinischen Hochschule Brandenburg (MHB)

Publikationen  

• Endovascular interventions in outpatient care.
  Thieme M, Krankenberg H, Schilling T, Betge S, Korosoglou G, Rammos C, Vosseler M, Espinola-Klein C, Heilmeier B, Müller OJ, Langhoff R, Malyar N, Blessing E, Caspary L, Linnemann B, Heiss C, Ito W; DGA – German Society of Angiology Board and ESVM – European Society of Vascular Medicine Board. Vasa. 2023 May;52(3):141-146. doi: 10.1024/0301-1526/a001067. Epub 2023 Mar 20. PMID: 36935626 Free article.

• Best crossing of peripheral chronic total occlusions.
  Korosoglou G, Schmidt A, Lichtenberg M, Torsello G, Grözinger G, Mustapha J, Varcoe RL, Wulf I, Heilmeier B, Müller OJ, Zeller T, Blessing E, Langhoff R. Vasa. 2023 May;52(3):147-159. doi: 10.1024/0301-1526/a001066. Epub 2023 Mar 16.

• Crossing Algorithm for Infrainguinal Chronic Total Occlusions: An Interdisciplinary Expert Opinion Statement.
  Korosoglou G, Schmidt A, Lichtenberg M, Torsello G, Grözinger G, Mustapha J, Varcoe RL, Zeller T, Blessing E, Langhoff R.
  JACC Cardiovasc Interv. 2023 Feb 13;16(3):317-331. doi: 10.1016/j.jcin.2022.11.036. PMID: 36792256 Review.

• Cardiac Troponins for the Clinical Management of Patients with Claudication and without Cardiac Symptoms.
  Mouselimis D, Hagstotz S, Lichtenberg M, Donas KP, Heinrich U, Avranas K, Dimitriadis Z, Blessing E, Langhoff R, Frey N, Katus HA, Korosoglou G. J Clin Med. 2022 Dec 8;11(24):7287. doi: 10.3390/jcm11247287. PMID: 36555902 Free PMC article.

• Low-Dose vs High-Dose Paclitaxel-Coated Balloons for Femoropopliteal Lesions: 2-Year Results From the COMPARE Trial.
  Steiner S, Schmidt A, Zeller T, Tepe G, Thieme M, Maiwald L, Schröder H, Euringer W, Popescu C, Brechtel K, Brucks S, Blessing E, Schuster J, Langhoff R, Schellong S, Weiss N, Beschorner U, Wittig T, Scheinert D.
  JACC Cardiovasc Interv. 2022 Oct 24;15(20):2093-2102. doi: 10.1016/j.jcin.2022.08.004. Epub 2022 Sep 28. PMID: 36265942 Clinical Trial.

• Efficacy of a Drug-Eluting Stent Versus Bare Metal Stents for Symptomatic Femoropopliteal Peripheral Artery Disease: Primary Results of the EMINENT Randomized Trial.
  Gouëffic Y, Torsello G, Zeller T, Esposito G, Vermassen F, Hausegger KA, Tepe G, Thieme M, Gschwandtner M, Kahlberg A, Schindewolf M, Sapoval M, Diaz-Cartelle J, Stavroulakis K; EMINENT Investigators. Circulation. 2022 Nov 22;146(21):1564-1576. doi: 10.1161/CIRCULATIONAHA.122.059606. Epub 2022 Oct 18.PMID: 36254728 Free article. Clinical Trial.

• PERFORMANCE 1 study: Novel carotid stent system with integrated post-dilation balloon and embolic protection device.
  Langhoff R, Petrov I, Kedev S, Milosevic Z, Schmidt A, Scheinert D, Schofer J, Sievert H, Sedgewick G, Saylors E, Sachar R, Cremonesi A, Micari A.Catheter Cardiovasc Interv. 2022 Nov;100(6):1090-1099. doi: 10.1002/ccd.30410. Epub 2022 Oct 13. PMID: 36229946

• Safety and Effectiveness of Endovascular Therapy for the Treatment of Peripheral Artery Disease in Patients with and without Diabetes Mellitus.
  Korosoglou G, Giusca S, Langhoff R, Lichtenberg M, Lawall H, Schellong S, Stausberg J, Hoffmann U, Enders D, Malyar N. Angiology. 2022 Mar 24:33197221075857. doi: 10.1177/00033197221075857. Online ahead of print. PMID: 35324343

• 2-Year Results With a Sirolimus-Eluting Self-Expanding Stent for Femoropopliteal Lesions: The First-in-Human ILLUMINA Study. Steiner S, Honton B, Langhoff R, Chiesa R, Kahlberg A, Thieme M, Zeller T, Garot P, Commeau P, Cremonesi A, Marone EM, Sauguet A, Scheinert D. JACC Cardiovasc Interv. 2022 Mar 28;15(6):618-626. doi: 10.1016/j.jcin.2021.12.034. Epub 2022 Feb 23. PMID: 35219622 Free article.

• “Real-World Study of a Dual-Layer Micromesh Stent in Elective Treatment of Symptomatic and Asymptomatic Carotid Artery Stenosis (ROADSAVER)”.
  Kedev S, Müller-Hülsbeck S, Langhoff R. Cardiovasc Intervent Radiol. 2022 Mar;45(3):277-282. doi: 10.1007/s00270-021-03051-5. Epub 2022 Jan 18. PMID: 35043241 Free PMC article.

• The Real-World CONSEQUENT ALL COMERS Study: Predictors for Target Lesion Revascularization and Mortality in an Unselected Patient Population.
  Langhoff R, Arjumand J, Waliszewski M, Reimer P, Härtel D, Hohl C, Raut W, Romani S, Alós J, Martínez E, Schmidt A, Yahya SA, Riazi H, Korosoglou G.  Angiology. 2021 Mar 29:3319721997314. doi: 10.1177/0003319721997314. Online ahead of print. PMID: 33779291

• Antithrombotic Treatment for Peripheral Arterial Occlusive Disease. 
  Hardung D, Behne A, Boral M, Giesche C, Langhoff R. Dtsch Arztebl Int. 2021 Jul 2;118(Forthcoming):arztebl.m2021.0157. doi: 10.3238/arztebl.m2021.0157. Online ahead of print. PMID: 33734081 Free article.

• Provisional focal stenting of complex femoropopliteal lesions using the Multi-LOC multiple stent delivery system – 12-month results from the LOCOMOTIVE EXTENDED study.
  Amendt K, Zeller T, Proczka R, Beschorner U, Troisi N, Waliszewski M, Langhoff R, Krankenberg H, Hansch A, Krcmar T, Vidjak V, Nolte-Ernsting C, Hansen A, Sigl M.Amendt K, et al. Among authors: langhoff r. Vasa. 2020 Nov 26:1-8. doi: 10.1024/0301-1526/a000927. Online ahead of print.Vasa. 2020. PMID: 33238823

• Impact of chemotherapeutic effects on the pathophysiology of the arterial wall – insights from peripheral arterial disease.
  Lange C, Ngare N, Hillmeister P, Bramlage P, Langhoff R, Buschmann I.Lange C, et al. Among authors: langhoff r. Vasa. 2020 Nov 3:1-5. doi: 10.1024/0301-1526/a000923. Online ahead of print.Vasa. 2020. PMID: 33140700

• Demographic and procedural characteristics in the RECording COurses of vasculaR Diseases (RECCORD) registry – the first 1000 patients.
  Malyar N, Stausberg J, Langhoff R, Tatò F, Kalka C, Ito WD, Böhme J, Arjumand J, Stegemann J, Lawall
  H, Schellong S, Lichtenberg M, Hoffmann U.Vasa. 2020 Jul 1:1-7. doi: 10.1024/0301-1526/a000882.
  Online ahead of print.

• COMPARE: prospective, randomized, non-inferiority trial of high- vs. low-dose paclitaxel drug-coated balloons for femoropopliteal interventions.
  Steiner S, Schmidt A, Zeller T, Tepe G, Thieme M, Maiwald L, Schröder H, Euringer W, Ulrich M, Brechtel K, Brucks S, Blessing E, Schuster J, Langhoff R, Schellong S, Weiss N, Scheinert D.
  Eur Heart J. 2020 Jan 28:ehaa049. doi: 10.1093/eurheartj/ehaa049.

• First-in-Human Experience With Sirolimus-Eluting Self-Expanding Stent for Femoropopliteal Lesions.
  Steiner S, Sauguet A, Langhoff R, Kahlberg A, Thieme M, Zeller T, Garot P, Commeau P, Cremonesi A, Marone EM, Scheinert D.Steiner S, et al.
  J Am Coll Cardiol. 2019 Oct 29;74(17):2216-2218. doi: 10.1016/j.jacc.2019.08.1019.

• Dual Pathway Inhibition in Atherosclerosis – Which Patients Benefit?
  Hardung D, Behne A, Langhoff R. Dtsch Med Wochenschr. 2019 Oct;144(20):1384-1389. doi: 10.1055/a-0868-3360. Epub 2019 Oct 8.

• The ILLUMINA study: First-in-man experience with an innovative sirolimus-eluting self-expanding stent for femoropopliteal lesions.
  Steiner S, Sauguet A, Langhoff R, Chiesa R, Kahlberg A, Zeller, T, Scheinert D.
  J Am Coll Cardiol. 2019 Oct 29;74(17):2216-2218. doi: 10.1016/j.jacc.2019.08.1019.

• Double Filtration During Carotid Artery Stenting Using a Novel Post-Dilation Balloon With Integrated Embolic Protection.
  Langhoff R, Schofer J, Scheinert D, Schmidt A, Sedgewick G, Saylors E, Sachar R, Sievert H, Zeller T.
  JACC Cardiovasc Interv. 2019 Feb 25;12(4):395-403.

• Focal Stenting of Complex Femoropopliteal Lesions with the Multi-LOC Multiple Stent Delivery System: 12-Month Results of the Multicenter LOCOMOTIVE Study.
  Sigl M, Beschorner U, Zeller T, Waliszewski M, Langhoff R, Tautenhahn J, Amendt K.
  Cardiovasc Intervent Radiol. 2019 Feb;42(2):169-175. doi: 10.1007/s00270-018-2095-9. Epub 2018 Oct 25.

• Update ESC-Guideline 2017: Focus on PAD.
  Sansone R, Busch L, Langhoff R.
  Dtsch Med Wochenschr. 2018 Oct;143(20):1455-1459. doi: 10.1055/a-0588-7317. Epub 2018 Oct 4.

• Evaluation of a new dual-layer micromesh stent system for the carotid artery: 12-month results from the CLEAR-ROAD study.
  Bosiers M, Deloose K, Torsello G, Scheinert D, Maene L, Peeters P, Müller-Hülsbeck S, Sievert H, Langhoff R, Callaert J, Setacci C, Wauters J.
  EuroIntervention. 2018 Nov 20;14(10):1144-1146. doi: 10.4244/EIJ-D-18-00230.

• Carotid stenosis – basing treatment on individual patients’ needs. Optimal medical therapy alone or accompanied by stenting or endarterectomy.
  Langhoff R.
  Vasa. 2018 Jan;47(1):7-16. doi: 10.1024/0301-1526/a000668. Epub 2017 Oct 24. Review.

• Directional Atherectomy Followed by a Paclitaxel-Coated Balloon to Inhibit Restenosis and Maintain Vessel Patency: Twelve-Month Results of the DEFINITIVE AR Study.
  Zeller T, Langhoff R, Rocha-Singh KJ, Jaff MR, Blessing E, Amann-Vesti B, Krzanowski M, Peeters P, Scheinert D, Torsello G, Sixt S, Tepe G; DEFINITIVE AR Investigators.
  Circ Cardiovasc Interv. 2017 Sep;10(9). pii: e004848. doi: 10.1161/CIRCINTERVENTIONS.116.004848.

• First clinical experience with the Multi-LOC multiple stent delivery system for focal stenting in long femoro-popliteal lesions.
  Amendt K, Beschorner U, Waliszewski M, Sigl M, Langhoff R, Thalwitzer J, Redlich U, Vogel B, Härtel D, Zeller T.
  Vasa. 2017 Oct;46(6):452-461. doi: 10.1024/0301-1526/a000658. Epub 2017 Aug 31.

• Rationale and design of the RECording COurses of vasculaR Diseases registry (RECCORD registry).
  M Malyar N, Stausberg J, Ito WD, Kölble H, Langhoff R, Lawall H, Lichtenberg M, Stegemann J, Treitl M, Weiss N, Hoffmann U.
  Vasa. 2017 Jul;46(4):262-267. doi: 10.1024/0301-1526/a000631. Epub 2017 May 2.

• Credentialing in interventional therapy in Europe – comparison of curricula including endovascular therapy of arterial diseases.
  Schulte KL, Jungmann PM, Makaloski V, Goncalves L, Steinbauer M, Vonberg S, Doerr BB, Langhoff R, Baumann F.
  Vasa. 2017 May;46(3):169-176. doi: 10.1024/0301-1526/a000618. Epub 2017 Feb 27. Review.

• Carotid Artery Stenting
  Langhoff R, Büttner F.
  Dtsch Med Wochenschr. 2017 Feb;142(3):152-156. doi: 10.1055/s-0042-116620. Epub 2017 Feb 10. Review.

• Promising role of drug-coated balloons in the tibial vessels?
  Langhoff R, Behne A, Buschmann E.
  J Cardiovasc Surg (Torino). 2016 Oct;57(5):667-76. Review.

• The CLEAR-ROAD study: evaluation of a new dual layer micromesh stent system for the carotid artery.
  Bosiers M, Deloose K, Torsello G, Scheinert D, Maene L, Peeters P, Müller-Hülsbeck S, Sievert H, Langhoff R, Bosiers M, Setacci C.
  EuroIntervention. 2016 Aug 5;12(5):e671-6.

• Primary Self-EXPANDing Nitinol Stenting vs Balloon Angioplasty With Optional Bailout Stenting for the Treatment of Infrapopliteal Artery Disease in Patients With Severe Intermittent Claudication or Critical Limb Ischemia (EXPAND Study).
  Schulte KL, Pilger E, Schellong S, Tan KT, Baumann F, Langhoff R, Torsello G, Zeller T, Amendt K, Brodmann M; EXPAND Investigators.
  J Endovasc Ther. 2015 Oct;22(5):690-7.

• Carotid stenting with distal protection in high-surgical-risk patients: one-year results of the ASTI trial.
  Bosiers M, Scheinert D, Mathias K, Langhoff R, Mudra H, Diaz-Cartelle J.
  Cardiovasc Intervent Radiol. 2015 Apr;38(2):295-303.

• Offroad re-entry catheter system for subintimal recanalization of chronic total occlusions in femoropopliteal arteries: primary safety and effectiveness results of the re-route trial.
  Schmidt A, Keirse K, Blessing E, Langhoff R, Diaz-Cartelle J; European Study Group.
  J Cardiovasc Surg (Torino). 2014 Aug;55(4):551-8.

• Outcome of carotid angioplasty with a novel open-cell carotid stent system.
  Langhoff R, Mudra H, Waliszewski M, Reimers B, Berge J, Setacci C, Beyssen B.
  Vasc Endovascular Surg. 2014 May;48(4):317-24.

• Successful revascularization of chronic total occlusion of lower extremity arteries: a wire only and bail out use of re-entry device approach.
  Langhoff R, Stumpe S, Treitl M, Schulte KL.
  J Cardiovasc Surg (Torino). 2013 Oct;54(5):553-9.

• The diagnosis, treatment and follow-up of extracranial carotid stenosis.
  Eckstein HH, Kühnl A, Dörfler A, Kopp IB, Lawall H, Ringleb PA; Multidisciplinary German-Austrian guideline based on evidence and consensus.
  Dtsch Arztebl Int. 2013 Jul;110(27-28):468-76. doi: 10.3238/arztebl.2013.0468. Epub 2013 Jul 8. Review.

• Extracranial carotid stenosis
  Langhoff R; Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften e.V.
  Dtsch Med Wochenschr. 2013 Jun;138(23):1200-3. doi: 10.1055/s-0033-1343135. Epub 2013 May 29. German

• MISAGO 2: one-year outcomes after implantation of the Misago self-expanding nitinol stent in the superficial femoral and popliteal arteries of 744 patients.
  Schulte KL, Kralj I, Gissler HM, Bagnaschino LA, Buschmann I, Pernès JM, Haage P, Goverde P, Beregi JP, Válka M, Boudny J, Geibel T, Velkoborsky M, Zähringer M, Paetzel C, Fanelli F, Müller-Hülsbeck S, Zeller T, Langhoff R.
  J Endovasc Ther. 2012 Dec;19(6):774-84. doi: 10.1583/JEVT-12-3861MR.1.
  Select item 22926705

• Reocclusion caused by stent fracture implanted in the subclavian artery ostium: a case report.
  Shinozaki N, Langhoff R, Schulte KL.
  Cardiovasc Interv Ther. 2013 Jan;28(1):111-4.

• Arterial occlusive disease. Catheter-directed thrombolytic therapy
  Stelzner C, Langhoff R.
  Internist (Berl). 2011 Nov;52(11):1276, 1278-80, 1282-3. doi: 10.1007/s00108-011-2867-7. German.

• Therapeutic arteriogenesis in peripheral arterial disease: combining intervention and passive training.
  Bondke Persson A, Buschmann EE, Lindhorst R, Troidl K, Langhoff R, Schulte KL, Buschmann I.
  Vasa. 2011 May;40(3):177-87.

• MISAGO 1: first-in-man clinical trial with Misago nitinol stent.
  Schulte KL, Müller-Hülsbeck S, Cao P, Becquemin JP, Langhoff R, Charalambous N, Desgranges P, Kobeiter H, Midulla M, Vladimir Borovicanin V, Paunovic D, Beregi JP.
  EuroIntervention. 2010 Jan;5(6):687-91.

• Nitinol stent implantation in TASC A and B superficial femoral artery lesions: the Femoral Artery Conformexx Trial (FACT).
  Zeller T, Tiefenbacher C, Steinkamp HJ, Langhoff R, Wittenberg G, Schlüter M, Buergelin K, Rastan A, Krumsdorf U, Sixt S, Schulte CL, Tübler T, Krankenberg H.
  J Endovasc Ther. 2008 Aug;15(4):390-8. doi: 10.1583/08-2461.1.

• Rational diagnostic and treatment of diseases of the cerebrocervical circulation.
  Langhoff R.
  Vasa. 2008 May;37(2):117-26. doi: 10.1024/0301-1526.37.2.117. Review.

• SPACE and EVA-3S: two failed studies?
  Theiss W, Langhoff R, Schulte KL.
  Vasa. 2007 May;36(2):77-9.

• Are the TASC recommendations for diagnosis and treatment of PAOD still relevant?
  Langhoff R, Schulte KL.
  Hamostaseologie. 2006 Aug;26(3):208-13. German.

• Hemobahn-endoprosthesis: long-term experience (< or = 4 years follow-up) with percutaneous application in stenoses and occlusions of the superficial femoral artery
  Fischer M, Langhoff R, Schulte KL.
  Zentralbl Chir. 2003 Sep;128(9):740-5.

• Roundtable Discussion: The Evolution of the CLI Treatment Algorithm
  A multidisciplinary panel shares insights on practice patterns, treatment algorithms, and hopes for future solutions for this challenging disease.
  Ralf Langhoff, MD; Robert A. Lookstein, MD; Miguel Montero-Baker, MD; and Jihad A. Mustapha, MD, FACC, FSCAI
  Endovascular Today (ISSN 1551-1944 print and ISSN 2689-792X online), May 2019 Supplement

• LUTONIX^® DCB: Changing the Treatment Landscape for BTK Arteries
  With Marianne Brodmann, MD; Marc Sirvent, MD, FEBVS; Ralf Langhoff, MD; Christoph A. Binkert, MD, FCIRSE, FSIR; and Luis Mariano Palena, MD
  Endovascular Today (ISSN 1551-1944 print and ISSN 2689-792X online), May 2019

• First Procedure in Asia Performed With B. Braun’s VascuFlex Multi-Loc Multiple Stent Delivery System
  Shaiful Azmi bin Yahaya, MD, Kumara Ganesan, and Ralf Langhoff, MD
  Endovascular Today (ISSN 1551-1944 print and ISSN 2689-792X online), May 2018

• The Importance of Vessel Preparation
  Properly preparing lesions before use of drug-eluting technologies has become a crucial step of the treatment algorithm.
  Ralf Langhoff, MD
  Endovascular Today (ISSN 1551-1944 print and ISSN 2689-792X online), September 2018 Supplement

• VascuFlex^® Multi-LOC: Spot Stenting With SeQuent^® Please OTW DCB
  Realizing the concept of leave-less-behind after DCB angioplasty in atherosclerotic lesions of the femoropopliteal artery.
  Klaus Amendt, MD, Ralf Langhoff, MD
  Endovascular Today (ISSN 1551-1944 print and ISSN 2689-792X online), May 2017

• Expert Opinion on When to Use DCBs
  Ralf Langhoff, MD
  Endovascular Today (ISSN 1551-1944 print and ISSN 2689-792X online), May 2015 Supplement

• Lehrbuchbeitrag: Rationelle Diagnostik und Therapie in der Inneren Medizin
  Ausstattung: Loseblattwerk & Online Resource, 2020, Urban & Fischer in Elsevier Verlag
  978-3-437-22136-1 (ISBN)